Literature DB >> 16806235

Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice.

Giuseppe Danilo Norata1, Patrizia Marchesi, Silvia Passamonti, Angela Pirillo, Francesco Violi, Alberico Luigi Catapano.   

Abstract

A strong negative correlation between polyphenols consumption and coronary heart disease has been extensively documented. These results prompted investigations on the mechanisms responsible for polyphenols effects in cardiovascular disease. The aim of this work was to investigate in apoE KO mice the effect of P183/1 (a mixture of cathechin, caffeic acid and resveratrol) on atherosclerosis and gene expression patterns in the vascular wall. ApoE KO mice were fed a diet supplemented with P183/1, 40 and 160 mg/kg body weight/day for 8 weeks. The supplementation with the high dose of P183/1 significantly reduced the presence of atherosclerotic plaque by 40 and 36% in the aortic sinus and in the ascending aorta, respectively. This reduction was associated with a reduced expression of markers for macrophages, lymphocytes (both Th1 and Th2) and of MCP-1, MIP-1alpha, MIP-1beta, CCR1, CCR2 and ET1 in the vascular wall. In conclusion, P183/1 supplementation significantly decreases atherosclerosis in ApoE KO mice by affecting inflammatory cells recruitment and expression of pro-inflammatory chemokines in the vascular wall.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806235     DOI: 10.1016/j.atherosclerosis.2006.05.047

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  31 in total

1.  De-alcoholised white and red wines decrease inflammatory markers and NF-κB in atheroma plaques in apoE-deficient mice.

Authors:  Nuria Martínez; Kelly Casós; Paolo Simonetti; María P Sáiz; Juan J Moreno; María T Mitjavila
Journal:  Eur J Nutr       Date:  2012-05-29       Impact factor: 5.614

2.  Multiple anti-inflammatory and anti-atherosclerotic properties of red wine polyphenolic extracts: differential role of hydroxycinnamic acids, flavonols and stilbenes on endothelial inflammatory gene expression.

Authors:  Nadia Calabriso; Egeria Scoditti; Marika Massaro; Mariangela Pellegrino; Carlo Storelli; Ilaria Ingrosso; Giovanna Giovinazzo; Maria Annunziata Carluccio
Journal:  Eur J Nutr       Date:  2015-02-28       Impact factor: 5.614

3.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

4.  Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians.

Authors:  Vèronique Habauzit; Christine Morand
Journal:  Ther Adv Chronic Dis       Date:  2012-03       Impact factor: 5.091

5.  Resveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice.

Authors:  Alba Carreras; Shelley X L Zhang; Isaac Almendros; Yang Wang; Eduard Peris; Zhuanhong Qiao; David Gozal
Journal:  Endocrinology       Date:  2014-11-18       Impact factor: 4.736

Review 6.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

7.  Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea.

Authors:  A Carreras; S X Zhang; E Peris; Z Qiao; Y Wang; I Almendros; D Gozal
Journal:  Int J Obes (Lond)       Date:  2014-10-09       Impact factor: 5.095

Review 8.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes.

Authors:  John P Cullen; David Morrow; Ying Jin; Nicholas von Offenberg Sweeney; James V Sitzmann; Paul A Cahill; Eileen M Redmond
Journal:  Atherosclerosis       Date:  2007-05-17       Impact factor: 5.162

10.  Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice.

Authors:  Ji Zhou; Geoff H Werstuck; Sárka Lhoták; Yuan Y Shi; Vivienne Tedesco; Bernardo Trigatti; Jeffrey Dickhout; Alana K Majors; Patricia M DiBello; Donald W Jacobsen; Richard C Austin
Journal:  FASEB J       Date:  2008-03-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.